GKSL
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited (GKSL) Stock Analysis & Case Study
Is GKSL a good buy? The data-driven verdict.
Gujarat Kidney And Super Speciality Limited (GKSL) trades at ₹134,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, Gujarat Kidney And Super Speciality Limited (GKSL) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 68.4× earnings, ROE of 11.1%. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
GKSL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How GKSL ranks against the 2,373 companies in our screener
- GKSL's market cap of 1,060 Cr ranks in the 40th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's book value of ₹32 ranks in the 24th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's promoter holding of 71.4% ranks in the 78th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's 3-year profit (PAT) growth of 1058.0% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's 3-year revenue growth of 1058.0% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's debt-to-equity ratio of 0.11x is lower than 75% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is GKSL overvalued? GKSL P/E vs peers
GKSL trades at 68.4× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
The bull case for GKSL
- Gujarat Kidney And Super Speciality Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
The bear case & risks
- GKSL's P/E of 68.4x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- GKSL's return on equity of 11.1% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
GKSL Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. GKSL scores 5/8, mixed financial health.
GKSL MTF margin & leverage across 8 brokers
Margin Trading Facility lets you buy GKSL with part of the capital. Lower margin % = higher leverage. Rates compared across 8 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Zerodha | 26.84% | 3.7× |
| Groww | 26.89% | 3.7× |
| Dhan | 50.00% | 2.0× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 26.92% | 3.7× |
| Pocketful | 26.95% | 3.7× |
| Fyers | 50.00% | 2.0× |
| Share IndiaCHEAPEST | 26.78% | 3.7× |
Compare every broker on the GKSL MTF page.
About Gujarat Kidney And Super Speciality Limited: sector, index & market-cap context
Gujarat Kidney And Super Speciality Limited (GKSL) is a small-cap NSE-listed company, with a market capitalisation of ₹1,060 Cr. See more stocks on our screener.
How the GKSL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Gujarat Kidney And Super Speciality Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
GKSL analysis, FAQs
Is Gujarat Kidney And Super Speciality Limited (GKSL) a good buy?
On the numbers, Gujarat Kidney And Super Speciality Limited (GKSL) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 68.4× earnings, ROE of 11.1%. This is a data snapshot for research, not investment advice.
Is GKSL overvalued or undervalued?
GKSL trades at 68.4× earnings, expensive versus the ~22× long-run Nifty average.
What is the bull case for GKSL?
Gujarat Kidney And Super Speciality Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in GKSL?
GKSL's P/E of 68.4x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. GKSL's return on equity of 11.1% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.